PROMACTA (eltrombopag) for oral suspension Initial U.S. Approval: 2008

Category: .

PROMACTA (eltrombopag) for oral suspension Initial U.S. Approval: 2008

INDICATIONS AND USAGE
PROMACTA is a thrombopoietin receptor agonist indicated for the treatment of:
• thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
• thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
• patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
DOSAGE FORMS & STRENGTHS
• Tablets: 12.5 mg, 25 mg, 50 mg, 75 mg, and 100 mg
• For oral suspension: 25 mg
Manufactured By: GlaxoSmithKline
Prescribing Information URL: Click Here

Access to PROMACTA (eltrombopag) for oral suspension: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manufactured and marketed by Novartis under the trade name Promacta in the US and is marketed as Revolade in the EU. Novartis acquired the drug as a part of its asset swap deal with GlaxoSmithKline.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.